SysteMHC v.231201
Home Datasets Download Help About Update

Showing details for project SYSMHC00019



SampleIDNumReplicatesOrganismTissueTypeCellTypeMHCAllele
SampleID
NumReplicates
Organism
TissueType
CellType
MHCAllele
SYSMHC00019_Wangq_161024_Costello_USA_LA3ST 4 Human DRB1_0301,DRB1_1501
SYSMHC00019_Wangq_161024_Costello_USA_LA4ST 4 Human DRB1_1101,DRB1_1302
SYSMHC00019_Wangq_161024_Costello_USA_LA5PB 5 Human DRB1_0301,DRB1_0305
SYSMHC00019_Wangq_161024_Costello_USA_LA5SF 5 Human DRB1_0301,DRB1_0305
SYSMHC00019_Wangq_161024_Costello_USA_LA5ST 4 Human DRB1_0301,DRB1_0305
SYSMHC00019_Wangq_161024_Costello_USA_LA6ST 2 Human DRB1_0103,DRB1_0301
SYSMHC00019_Wangq_161024_Costello_USA_LA7SF_QE 1 Human DRB1_0403,DRB1_1501
SYSMHC00019_Wangq_161024_Costello_USA_LA7ST 2 Human DRB1_0403,DRB1_1501
SYSMHC00019_Wangq_161024_Costello_USA_LA8SF_QE 2 Human DRB1_0401,DRB1_1001
SYSMHC00019_Wangq_161024_Costello_USA_LA8ST_QE 1 Human DRB1_0401,DRB1_1001
SYSMHC00019_Wangq_161024_Costello_USA_RA2SF 5 Human DRB1_0101,DRB1_0401
SYSMHC00019_Wangq_161024_Costello_USA_RA2ST_QE 1 Human DRB1_0101,DRB1_0401
SYSMHC00019_Wangq_161024_Costello_USA_RA3ST 4 Human DRB1_0101,DRB1_0401
SYSMHC00019_Wangq_161024_Costello_USA_RA4PB 3 Human DRB1_0401,DRB1_1501
SYSMHC00019_Wangq_161024_Costello_USA_RA4SF 3 Human DRB1_0401,DRB1_1501
SYSMHC00019_Wangq_161024_Costello_USA_RA5ST 4 Human DRB1_0801,DRB1_1501
Showing 1 to 11 of 16 entries



Detailed view of sample SYSMHC00019_Wangq_161024_Costello_USA_LA6ST



IDSampleIDRawFileNameProcessCulture ConditionsDisease StateCommentsMHCClassPubMed IDPeptideIsolation MethodAntibodyMass SpectrometerLC SystemiRT PeptidesAcquisition ModeFragmentation MethodGradientGradient LengthFlow RateReplicate Number
ID
SampleID
RawFileName
Organism
Process
Tissue Type
Cell Type
Culture Conditions
Disease State
Comments
MHCClass
MHCAllele
PubMed ID
Peptide
Isolation Method
Antibody
Mass Spectrometer
LC System
iRT Peptides
Acquisition Mode
Fragmentation Method
Gradient
Gradient Length
Flow Rate
Replicate Number
SYSMHC00019 SYSMHC00019_Wangq_161024_Costello_USA_LA6ST SYSMHC00019_LA6ST_2_Orbitrap.raw in vivo Lyme arthritis disease duration .83 year class II 27726376 native Immunoaffinity L243 Orbitrap XL Waters noAcquity UPLC no DDA CID Buffer A contained 1% acetonitrile (ACN) and 0.1% formic acid in water, and buffer B contained 1% water and 0.1% formic acid in ACN. 52 min .5 uL/min 1
SYSMHC00019 SYSMHC00019_Wangq_161024_Costello_USA_LA6ST SYSMHC00019_LA6ST_1_Orbitrap.raw in vivo Lyme arthritis disease duration .83 year class II 27726376 native Immunoaffinity L243 Orbitrap XL Waters noAcquity UPLC no DDA CID Buffer A contained 1% acetonitrile (ACN) and 0.1% formic acid in water, and buffer B contained 1% water and 0.1% formic acid in ACN. 52 min .5 uL/min 2
Showing 1 to 1 of 2 entries